@COVID19Up:
A new study published (https://www.thelancet.com/journals/lansea/article/PIIS2772-3682(22)00046-4/fulltext) July 12 in The Lancet Regional Health Southeast Asia journal has found that nitric oxide nasal spray (NONS) can reduce the viral load of SARS-CoV-2 by 94% within 24 hours and by 99% by 48 hours.
“The robust double-blind trial demonstrated significant efficacy and remarkable safety of NONS,” Monika Tandon, Senior VP & Head, Clinical Development, Glenmark, and one of the authors of the study explained (https://www.onlymyhealth.com/study-finds-nasal-spray-lowers-covid-viral-load-1658309167).
“This therapy has the potential to make a crucial contribution to COVID-19 management, with its ease of use in the current highly transmissible phase of pandemic,” Tandon added in his statement.
The study was done during the Omicron and Delta surges in February.